Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 13.05.2024 2 Am J Obstet Gynecol 1 BMC Cancer 1 Br J Cancer 1 Cancer Chemother Pharmacol 2 Gynecol Oncol 2 Int J Cancer 1 Int J Gynaecol Obstet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. SUH-BURGMANN EJ, Hung YY, Schmittdiel JA
   Ovarian cancer risk among older patients with stable adnexal masses.
   Am J Obstet Gynecol. 2024 Apr 23:S0002-9378(24)00525.
   PubMed         Abstract available
   
   
2. HOW JA, Legarreta AF, Handley KF, Fellman B, et al
   Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
   Am J Obstet Gynecol. 2024 Jan 6:S0002-9378(24)00009.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. QUAN C, Chen X, Wen H, Wu X, et al
   Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
   BMC Cancer. 2024;24:565.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. KENKHUIS MF, Stelten S, Hartman YA, Brouwer CG, et al
   Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.
   Br J Cancer. 2024 May 8. doi: 10.1038/s41416-024-02694.
   PubMed         Abstract available
   
   

   
   Cancer Chemother Pharmacol

5. XU R, Yang X, Tang B, Mao Y, et al
   Combined treatment of All-trans retinoic acid with Tamoxifen suppresses ovarian cancer.
   Cancer Chemother Pharmacol. 2024 May 7. doi: 10.1007/s00280-024-04671.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

6. GONZALEZ-MARTIN A, Chung HC, Saada-Bouzid E, Yanez E, et al
   Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
   Gynecol Oncol. 2024;186:182-190.
   PubMed         Abstract available
   
   
7. PAPPAS TC, Roy Choudhury M, Chacko BK, Twiggs LB, et al
   Neural network-derived multivariate index assay demonstrates effective clinical performance in longitudinal monitoring of ovarian cancer risk.
   Gynecol Oncol. 2024;187:21-29.
   PubMed         Abstract available
   
   

   
   Int J Cancer

8. TAGUCHI A, Kato K, Furusawa A, Hara K, et al
   Heterogeneous treatment effect of dose-dense paclitaxel plus carboplatin therapy for advanced ovarian cancer.
   Int J Cancer. 2024 May 7. doi: 10.1002/ijc.34996.
   PubMed         Abstract available
   
   
9. FROMHAGE G, Obermayr E, Bednarz-Knoll N, Van Gorp T, et al
   Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium.
   Int J Cancer. 2024 May 6. doi: 10.1002/ijc.34976.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

10. TANG Y
    Letter to the editor: Searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2024 May 7. doi: 10.1002/ijgo.15594.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.